Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

Transgene slumps as viral cancer therapy fails phase 3 trial

Oncolytic virus therapy works to boost the immune response and spare healthy cells

- PMLiVE

Senior promotions continue at Porterhouse Medical

Porterhouse Medical Group is delighted to announce the promotion of Claire Pullen to senior account director.Claire has made a very positive impact since joining Porterhouse at the start of the...

Porterhouse Medical Group

- PMLiVE

Why everyone in pharma is bending over backwards to be agile

Flexibility is the new key to success

- PMLiVE

Still no ferry contracts for no-deal Brexit medicines supplies

Major £434m set aside for medicines supplies, but time running out

- PMLiVE

Boehringer posts solid first half as business revamp beds in

Jardiance helped to boost sales

Biomarin

BioMarin ticks over in Q2 ahead of gene therapy filing

Haemophilia candidate valrox will be a game-changer for company

- PMLiVE

Roche reveals yet another Spark takeover delay

Are concerns about haemophilia dominance the cause?

- PMLiVE

GCI Health unveils German expansion

Adds 30 healthcare specialists

- PMLiVE

Q&A: Jessica Pacey

PME interviews the founder and chief executive of newly launched health comms agency, 67health

- PMLiVE

Publicis Resolute set to launch in Asia Pacific

Glen Halliwell to lead expansion

- PMLiVE

Lilly boosted by survival data for key growth drug Verzenio

Chases Pfizer's Ibrance

- PMLiVE

White House unveils plans to reimport medicines from Canada

Unthinkable to previous administrations, but scepticism rife amid flurry of policy ideas

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links